DELOISA KELLEY: Open Payments
NPI 1134383946 · CANANDAIGUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,532 in 70 payments from 14 companies in 2025. Trend: 2023 $706 · 2024 $245 · 2025 $1,532
Food & beverage: $1,532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $317 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $289 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $214 |
| Axsome Therapeutics, Inc. | 5 | $154 |
| Otsuka America Pharmaceutical, Inc. | 9 | $136 |
| Braeburn Inc. | 2 | $123 |
| Vanda Pharmaceuticals Inc. | 4 | $101 |
| Lundbeck LLC | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Almatica Pharma LLC | 1 | $27 |
Products named: CAPLYTA, VRAYLAR, TRINTELLIX, Auvelity, BRIXADI, REXULTI, HETLIOZ, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
